Home
About
Leadership
Medical Advisory Board (AC5)
Scientific & Clinical Advisors
Corporate Mission
Products
Ordering Information
Intellectual Property
AC5 Advanced Wound System
Technology
Platform
Preclinical Data
Clinical Data
Pipeline
Pipeline Opportunity
Investors
Investor Relations
IR Overview
News
Press Releases
IR Calendar
Presentations
Other News
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Governance Documents
Contact
Home
Investors
News
Press Releases
Investors
Overview
News
Press Releases
IR Calendar
Presentations
Other News
Stock Data
SEC Filings
Corporate Governance
Press Releases
All News
By Year:
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
09/3/19
Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 21st Annual Global Investment Conference
08/5/19
Arch Therapeutics Announces AC5 Self-Assembling Peptide Technology Platform Demonstrates Antimicrobial Activity in Two Studies and Provides CE Marking Status Update for AC5™ Topical Hemostat
05/30/19
Arch Therapeutics to Provide Corporate Update at the 9th Annual LD Micro Invitational
05/13/19
Arch Therapeutics, Inc. $2.8 Million Registered Direct Offering
04/24/19
Arch Therapeutics Announces Attendance at 2019 Symposium on Advanced Wound Care Conference (SAWC) and Release of a New AC5TM Topical Gel Video
03/11/19
Arch Therapeutics to Provide Corporate Update at the 31st Annual ROTH Conference
02/5/19
Arch Therapeutics to Provide Corporate Update at the 2019 BIO CEO & Investor Conference
12/20/18
Arch Therapeutics to Provide Corporate Update at the 11th Annual Biotech Showcase™ 2019 Conference on January 8th, 2019
12/17/18
Arch Therapeutics Receives 510(k) Clearance from the US FDA for AC5™ Topical Gel
12/6/18
Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event
<< Previous
1...
3
4
5
6
7
8
9
10
11
12
...14
Next >>
Show All